skin canceer
Merck and Pfizer’s joint skin cancer drug gets EU approval
September 21, 2017Sales and Marketing Bavencio, Cancer, Merck, Pfizer, merkel cell carcinoma, pharma, pharmaceutical, skin canceer
Merck KGaA and Pfizer have announced that European authorisation of their jointly developed drug Bavencio (avelumab) as a monotherapy in …
Latest content
October 28, 2026
Acumetis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
